Cookies

Like most websites The Cannabis Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Business & Profession Legislation & policy, Terpene & residual solvent analysis, Pesticide analysis, Potency testing

Policy Précis

Epidiolex descheduled. For the first time, a cannabinoid medicine (Epidiolex, a CBD-based therapy used to treat Dravet syndrome) has been descheduled by the US DEA. Read the press release from manufacturer GW Pharma here.

EVALI leads to tighter cannabis controls. Oregon officials will carry out random testing for unlicensed additives in cannabis products and Washington State passed an emergency rule banning vape products containing vitamin E acetate. A second rule “requires manufacturers of THC products to disclose all compounds (including ingredients, solvents, additives, etc.) used in the production and processing as well as the sources of all vapor products."

Read the full article now

Log in or register to read this article in full and gain access to The Cannabis Scientist’s entire content archive. It’s FREE and always will be!

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Cannabis Scientist magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

About the Author

Charlotte Barker

After studying biology at Imperial College London, I got my start in biomedical publishing as a commissioning editor for healthcare journals, and have spent my career covering everything from early-stage research to clinical medicine. I joined Texere Publishing in 2014, attracted by the creativity, talent and passion of the team. As Editor of The Analytical Scientist, I help scientists share their stories in vibrant and engaging content that reflects their passion and hard work.

Register to The Cannabis Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Cannabis Scientist magazine

Register